The FDA approves Dr. Reddy’s Laboratories’ (RDY +2.3%) Elyxyb (celecoxib oral solution 25 mg/mL) for the acute treatment of migraine in adults with or without aura.
The company plans to commercialize the product through partners.
https://seekingalpha.com/news/3570371-fda-oks-dr-reddys-migraine-med-elyxyb
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.